▶ 調査レポート

世界の関節内補充療法市場

• 英文タイトル:Market Study on Viscosupplementation: Surge in lifestyle-related disorders to boost Viscosupplementation Demand

Persistence Market Researchが調査・発行した産業分析レポートです。世界の関節内補充療法市場 / Market Study on Viscosupplementation: Surge in lifestyle-related disorders to boost Viscosupplementation Demand / MRC2303A102資料のイメージです。• レポートコード:MRC2303A102
• 出版社/出版日:Persistence Market Research / 2022年12月16日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社発行の当調査レポートでは、世界の関節内補充療法市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、主要成功要因、市場需要分析、市場価値分析、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、種類別(単回注射、3回注射、5回注射)、エンドユーザー別(病院、整形外科クリニック/外来手術センター (ASC))、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ)の情報が含まれています。なお、当市場の主要企業には、Sanofi、Anika Therapeutics, Inc.、SEIKAGAKU CORPORATION、Zimmer Biomet、Smith & Nephew PLC、Ferring Pharmaceutical B.V.、Lifecore Biomedical, LLC (Landec)、LG Life Sciences Ltd.、Fidia Farmaceutici S.p.A、F.Hoffmann-La Roche Ltd.などが含まれています。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データポイント
・主要成功要因
・市場需要分析
・市場価値分析

・世界の関節内補充療法市場規模:種類別
- 単回注射の市場規模
- 3回注射の市場規模
- 5回注射の市場規模

・世界の"関節内補充療法市場規模:エンドユーザー別
- 病院における市場規模
- 整形外科クリニック/外来手術センター (ASC)における市場規模

・世界の関節内補充療法市場規模:地域別
- 北米の関節内補充療法市場規模
- 中南米の関節内補充療法市場規模
- ヨーロッパの関節内補充療法市場規模
- アジア太平洋の関節内補充療法市場規模
- 中東/アフリカの関節内補充療法市場規模

・市場構造分析
・競争分析
・仮定
・調査手法

Viscosupplementation Market: Global Industry Analysis 2017-2021 & Opportunity Assessment 2022-2032

A recent market study published by Persistence Market Research on the Viscosupplementation market offers global industry analysis for 2017-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The Viscosupplementation market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Product Type

Single Injection
Three Injection
Five Injection

By End User

Hospitals
Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs)

By Region

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Report Chapters

Chapter 01 – Executive Summary
The executive summary of the Viscosupplementation market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Viscosupplementation market.

Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Viscosupplementation market in this chapter, which will help them understand basic information about the Viscosupplementation market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the Viscosupplementation market report.

Chapter 03 – Market Background
The associated industry assessment of the Viscosupplementation market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the Viscosupplementation market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the Viscosupplementation market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the Viscosupplementation market.

Chapter 04 – Viscosupplementation Market Analysis 2017-2021 and Forecast, 2022-2032
This section provides detailed analysis of the historical Viscosupplementation market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2021–2022) and an absolute opportunity for the forecast period (2022–2032).

Chapter 05 – Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032, by Product Type
Based on Product Type, the Viscosupplementation market is segmented into Single injection, three injection, five injection. In this chapter, readers can find market attractiveness analysis, based on Product type.

Chapter 06 – Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032, by End User
Based on End User, the Viscosupplementation market is segmented into, Hospitals, Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs). In this chapter, readers can find market attractiveness analysis, based on End User.

Chapter 07 – Viscosupplementation Market Analysis 2017-2021 and Opportunity Assessment 2022-2032 by Region
This chapter explains how the Viscosupplementation market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).

Chapter 08 – North America Viscosupplementation Market market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Viscosupplementation market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on components, End use, and countries in the North America region.

Chapter 09 – Latin America Viscosupplementation Market Analysis 2017-2021 & Forecast 2022-2032
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Viscosupplementation market in the Latin America region. This chapter also includes growth prospects of the Viscosupplementation market in leading LATAM countries such as Brazil and Mexico.

Chapter 10 – Europe Viscosupplementation Market Analysis 2017-2021 & Forecast 2022-2032
Important growth prospects of the Viscosupplementation market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, BENELUX, Nordics, Russia, and Rest of Europe are included in this chapter.

Chapter 11 – Asia Pacific Viscosupplementation Market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Viscosupplementation market in the South Asia region, along with a country-wise assessment that includes, China, Japan and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.

Chapter 12 – Middle East and Africa Viscosupplementation Market Analysis 2017-2021 & Forecast 2022-2032
This chapter offers insights into how the Viscosupplementation market is expected to grow in major countries in the MEA region such as GCC Countries, South Africa, and the Turkey, during the forecast period 2022-2032.

Chapter 13 – Key Countries 3D Mapping and Modeling Market Analysis
This chapter offers insights into how the Viscosupplementation market is expected to grow in key countries in the such as U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, BENELUX, Nordic, Rest of Europe, China, Japan, South Korea, GCC, South Africa, and Turkey during the forecast period 2022-2032.

Chapter 14 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the Viscosupplementation market along with their market presence analysis by region and product portfolio.

Chapter 15 – Competition Deep-Dive Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in the Viscosupplementation market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Sanofi, Anika Therapeutics Inc., Seikagaku Corporation, Zimmer Biomet, Smith & Nephew Plc.

Chapter 16 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a based to the information and statistics included in the Viscosupplementation market report.

Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the Viscosupplementation market.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Viscosupplementation Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Viscosupplementation Market (US$ Mn)

    4.2. Viscosupplementation Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Viscosupplementation Market Growth

        4.5.3. District Cooling Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Viscosupplementation Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Viscosupplementation Market Demand Analysis 2017-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2017-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Viscosupplementation Market Value Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2017-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        8.3.1. Single Injection

        8.3.2. Three Injection

        8.3.3. Five Injection

    8.4. Market Attractiveness Analysis By Product Type

9. Global Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        9.3.1. Hospitals

        9.3.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

    9.4. Market Attractiveness Analysis By End User

10. Global Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific

        10.3.5. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. U.S.

            11.4.1.2. Canada

            11.4.1.3. Rest of North America

        11.4.2. By Product Type

        11.4.3. By End User

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Product Type

        11.5.3. By End User

12. Latin America Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Brazil

            12.4.1.2. Mexico

            12.4.1.3. Rest of Latin America

        12.4.2. By Product Type

        12.4.3. By End User

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product Type

        12.5.3. By End User

13. Europe Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Germany

            13.4.1.2. France

            13.4.1.3. U.K.

            13.4.1.4. Italy

            13.4.1.5. Benelux

            13.4.1.6. Nordic Countries

            13.4.1.7. Rest of Europe

        13.4.2. By Product Type

        13.4.3. By End User

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product Type

        13.5.3. By End User

14. Asia Pacific Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. China

            14.4.1.2. Japan

            14.4.1.3. South Korea

            14.4.1.4. Rest of Asia Pacific

        14.4.2. By Product Type

        14.4.3. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product Type

        14.5.3. By End User

15. Middle East and Africa Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. GCC Countries

            15.4.1.2. South Africa

            15.4.1.3. Turkey

            15.4.1.4. Rest of Middle East and Africa

        15.4.2. By Product Type

        15.4.3. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product Type

        15.5.3. By End User

16. Key Countries Viscosupplementation Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. US Viscosupplementation Market Analysis

        16.2.1. Value Proportion Analysis by Market Taxonomy

        16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.2.2.1. By Product Type

            16.2.2.2. By End User

    16.3. Canada Viscosupplementation Market Analysis

        16.3.1. Value Proportion Analysis by Market Taxonomy

        16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.3.2.1. By Product Type

            16.3.2.2. By End User

    16.4. Mexico Viscosupplementation Market Analysis

        16.4.1. Value Proportion Analysis by Market Taxonomy

        16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.4.2.1. By Product Type

            16.4.2.2. By End User

    16.5. Brazil Viscosupplementation Market Analysis

        16.5.1. Value Proportion Analysis by Market Taxonomy

        16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.5.2.1. By Product Type

            16.5.2.2. By End User

    16.6. Germany Viscosupplementation Market Analysis

        16.6.1. Value Proportion Analysis by Market Taxonomy

        16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.6.2.1. By Product Type

            16.6.2.2. By End User

    16.7. France Viscosupplementation Market Analysis

        16.7.1. Value Proportion Analysis by Market Taxonomy

        16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.7.2.1. By Product Type

            16.7.2.2. By End User

    16.8. Italy Viscosupplementation Market Analysis

        16.8.1. Value Proportion Analysis by Market Taxonomy

        16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.8.2.1. By Product Type

            16.8.2.2. By End User

    16.9. BENELUX Viscosupplementation Market Analysis

        16.9.1. Value Proportion Analysis by Market Taxonomy

        16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.9.2.1. By Product Type

            16.9.2.2. By End User

    16.10. UK Viscosupplementation Market Analysis

        16.10.1. Value Proportion Analysis by Market Taxonomy

        16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.10.2.1. By Product Type

            16.10.2.2. By End User

    16.11. Nordic Countries Viscosupplementation Market Analysis

        16.11.1. Value Proportion Analysis by Market Taxonomy

        16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.11.2.1. By Product Type

            16.11.2.2. By End User

    16.12. China Viscosupplementation Market Analysis

        16.12.1. Value Proportion Analysis by Market Taxonomy

        16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.12.2.1. By Product Type

            16.12.2.2. By End User

    16.13. Japan Viscosupplementation Market Analysis

        16.13.1. Value Proportion Analysis by Market Taxonomy

        16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.13.2.1. By Product Type

            16.13.2.2. By End User

    16.14. South Korea Viscosupplementation Market Analysis

        16.14.1. Value Proportion Analysis by Market Taxonomy

        16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.14.2.1. By Product Type

            16.14.2.2. By End User

    16.15. GCC Countries Viscosupplementation Market Analysis

        16.15.1. Value Proportion Analysis by Market Taxonomy

        16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.15.2.1. By Product Type

            16.15.2.2. By End User

    16.16. South Africa Viscosupplementation Market Analysis

        16.16.1. Value Proportion Analysis by Market Taxonomy

        16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.16.2.1. By Product Type

            16.16.2.2. By End User

    16.17. Turkey Viscosupplementation Market Analysis

        16.17.1. Value Proportion Analysis by Market Taxonomy

        16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            16.17.2.1. By Product Type

            16.17.2.2. By End User

        16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

    17.1. Market Analysis by Tier of Companies

    17.2. Market Concentration

    17.3. Market Share Analysis of Top Players

    17.4. Market Presence Analysis

        17.4.1. By Regional footprint of Players

        17.4.2. Product footprint by Players

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive

        18.3.1. Sanofi

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Sales Footprint

            18.3.1.4. Strategy Overview

        18.3.2. Anika Therapeutics, Inc.

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Sales Footprint

            18.3.2.4. Strategy Overview

        18.3.3. SEIKAGAKU CORPORATION

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Sales Footprint

            18.3.3.4. Strategy Overview

        18.3.4. Zimmer Biomet

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Sales Footprint

            18.3.4.4. Strategy Overview

        18.3.5. Smith & Nephew PLC

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Sales Footprint

            18.3.5.4. Strategy Overview

        18.3.6. Ferring Pharmaceutical B.V.

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Sales Footprint

            18.3.6.4. Strategy Overview

        18.3.7. Lifecore Biomedical, LLC (Landec)

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio

            18.3.7.3. Sales Footprint

            18.3.7.4. Strategy Overview

        18.3.8. LG Life Sciences Ltd.

            18.3.8.1. Overview

            18.3.8.2. Product Portfolio

            18.3.8.3. Sales Footprint

            18.3.8.4. Strategy Overview

        18.3.9. Fidia Farmaceutici S.p.A

            18.3.9.1. Overview

            18.3.9.2. Product Portfolio

            18.3.9.3. Sales Footprint

            18.3.9.4. Strategy Overview

        18.3.10. F.Hoffmann-La Roche Ltd.

            18.3.10.1. Overview

            18.3.10.2. Product Portfolio

            18.3.10.3. Sales Footprint

            18.3.10.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology